Huang J, Zhang S-Y, Gao Y-M, Liu Y-F, Liu Y-B, Zhao Z-G, Yang K
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Cell Prolif. 2014 Aug;47(4):277-86. doi: 10.1111/cpr.12109. Epub 2014 Jun 6.
MicroRNAs are a class of small, non-coding RNAs that can negatively regulate protein-coding genes, and are associated with almost all known physiological and pathological processes, especially cancer. The number of studies documenting miRNA expression patterns in malignancy continues to expand rapidly, with continuously gained critical information regarding how aberrantly expressed miRNAs may contribute to carcinogenesis. miRNAs can influence cancer pathogenesis, playing a potential role as either oncogenes or tumour suppressors. Recently, several miRNAs have been reported to exert different regulatory functions in oesophageal cancer - the carcinoma typically arising from the epithelial lining of the oesophagus. These miRNAs also have potential clinical applications towards developing biomarkers or targets for possible use in diagnosis or therapy in oesophageal cancer. In this review, we have summarized the two (oncogenic or tumour suppressive) roles of miRNAs here, and their applications as potential biomarkers or therapeutic targets, which may illuminate future treatment for oesophageal cancer.
微小RNA是一类小的非编码RNA,可对蛋白质编码基因进行负调控,并且与几乎所有已知的生理和病理过程相关,尤其是癌症。记录恶性肿瘤中微小RNA表达模式的研究数量持续迅速增长,不断获得有关异常表达的微小RNA如何促进致癌作用的关键信息。微小RNA可影响癌症发病机制,作为癌基因或肿瘤抑制因子发挥潜在作用。最近,有报道称几种微小RNA在食管癌(一种通常起源于食管上皮的癌症)中发挥不同的调节功能。这些微小RNA在开发可能用于食管癌诊断或治疗的生物标志物或靶点方面也具有潜在的临床应用价值。在本综述中,我们总结了微小RNA的两种(致癌或抑癌)作用,以及它们作为潜在生物标志物或治疗靶点的应用,这可能为食管癌的未来治疗提供思路。